Tim Funnell

Tim Funnell serves as Director and Interim CEO at Ascend Gene & Cell Therapies. Ascend Gene & Cell Therapies operates in the research sector with approximately 170.0 employees. The company is headquartered in London, England. To date, Ascend Gene & Cell Therapies has raised 132524999.0 in total funding, with the most recent round being Series A.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 10,137 executive contacts are available in England.
• • Our database includes 201,469 c suite-level executives.

Outlook Microsoft Office 365 Amazon AWS Google Tag Manager Vimeo Mobile Friendly Typekit Squarespace ECommerce

gene therapy biotechnology research aav development advanced therapies biomanufacturing gmp manufacturing quality assurance process development analytical capabilities scalable manufacturing bioreactor systems fill-finish system clinical support vector design bioreactor size patient-focused solutions translational research high-yield production viral vector manufacturing chip-based screening pre-clinical services clinical dosage development biologics production quality control testing biotechnology partnerships innovation in therapy regulatory compliance bioprocess optimization transgene expression scalable production capabilities downstream processing supply chain management collaborative cmc aav factories customized filling technology plasmid systems automated rebuffering cost-effective manufacturing high-throughput formulation assay sensitivity product quality metrics industry alliances biomanufacturing services scientific innovation research & development contract development & manufacturing bioanalytical services cell-based assays viral platforms therapeutic modalities adeno-associated virus contract development & manufacturing organization cdmo pharmaceutical manufacturing biotechnology formulation development analytical development regulatory support clinical trials commercial manufacturing high-quality production scalable solutions life-science innovators immunotherapy oncolytic therapies viral vector production advanced biologics customer partnership transatlantic operations biopharmaceutical industry advanced therapy manufacturing customer service higher yields purity milestone achievement global r&d programs nanopore sequencing ocular gene therapy capabilities logistics & supply chain pharmaceuticals medical health care health wellness & fitness hospital & health care

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

How can I contact Tim Funnell?

Tim Funnell's verified email address is available on MessageCEO. They currently work at Ascend Gene & Cell Therapies. Pro subscribers can access direct email addresses for over 200,000 executives.

What company does Tim Funnell lead?

Tim Funnell is Director and Interim CEO at Ascend Gene & Cell Therapies, a company in the research sector with 170.0 employees. The company is based in London, England.

What industry is Tim Funnell in?

Tim Funnell works in the research industry as Director and Interim CEO at Ascend Gene & Cell Therapies. MessageCEO provides verified contact information for executives across all major industries.

Is Tim Funnell's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Tim Funnell's profile is kept up-to-date with the latest available information.

Last updated: April 11, 2026